New research suggests that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight far faster than those who end traditional lifestyle programs.
Published data in a prominent health publication shows that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month once they quit.
"People purchasing such medications must be cognizant of the danger of rapid rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
That rate of regain suggests a return to starting mass in about a year and a half.
Analyzing Therapies
The study, which examined dozens of studies involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Scientists emphasize that individuals who lose weight through lifestyle changes alone typically see a less rapid creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Fast Regain
Experts believe the mechanism of the jabs explains the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone levels far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making binge eating a significant risk."
A Lifelong Disease?
The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals contend that, given the significant potential of relapse, the therapy is often long-term.
This perspective is echoed by drug manufacturers, who say that the findings "emphasize the chronic nature of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Individuals who have come off the jabs describe a powerful resurgence of appetite.
"It was like a trigger flipping and I was suddenly ravenous," said an individual.
The struggle is worsened if individuals have not developed permanent lifestyle or habit modifications during treatment.
Significant Adoption
Figures indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, clinicians caution that while the jabs are effective agents for shedding pounds, they are not a permanent fix and lasting health benefits likely depends on integrated lifestyle management.